TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of General Internal Medicine
Division of Pediatrics
Division of Hematology & Oncology
Division of Hematology & Oncology
Taipei Chang Gung Medical Foundation
Division of Hematology & Oncology
更新時間：2023-09-19
張鴻Chang, Hung
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
horng@cgmh.org.tw
-
horng@cgmh.org.tw
Publication
12Publications
1
Chang H, Yeh HC, Su YC, Lee MH. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab. Journal of the Chinese Medical Association : JCMA 2008;71:579-82.
2
Chang H, Yanachkov IB, Michelson AD, et al. Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thrombosis research 2010;125:159-65.
3
Chang H, Hung YS, Lin TL, et al. Primary bone marrow diffuse large B cell lymphoma: a case series and review. Annals of hematology 2011;90:791-6.
4
Chang H, Tang TC, Hung YS, Lin TL, Kuo MC, Wang PN. Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series. Biomedical Journal. (former Chang Gung medical journal) 2011;34:65-74.
5
Chang H, Kuo MC, Shih LY, et al. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. European journal of haematology 2012;88:321-8.
6
Chang H, Yanachkov IB, Dix EJ, et al. Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation. Journal of thrombosis and haemostasis : Journal of Thrombosis and Haemostasis 2012;10:2573-80
7
Chang H, Shih LY, Michelson AD, et al. Clinical and Laboratory Significance of Defective P2Y Pathway Function in Patients with Myeloproliferative Neoplasms: A Pilot Study. Acta haematologica 2013;130:181-7.
8
Chang H, Tang TC. Surgical site spread of skeletal diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31:e141-3.
9
Chang H, Yanachkov I, Dix EJ et al. Antiplatelet Activity, P2Y₁ and P2Y₁₂ Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5',5'''-P¹,P⁴-dithio-P²,P³- chloromethylenetetraphosphate. PLoS One 2014 Apr 10;9(4):e94780
10
Chang H, Tang TC, Hung YS, Li PL, Kuo MC, Wu JH, Wang PN: Immune thrombocytopenia: effectiveness of frontline steroids and comparison of azathioprine, splenectomy and rituximab as second line treatment. Eur J Haematol 2018;101:549-555
1
2
